Literature DB >> 12627283

Viral and bacterial DNA in carotid atherosclerotic lesions.

S Watt1, B Aesch, P Lanotte, F Tranquart, R Quentin.   

Abstract

Atherosclerosis is a major health problem in industrialised countries. Several studies have suggested an association exists between certain microorganisms and the development of atherosclerosis. The aim of the study presented here was to assess the presence of viral or bacterial DNA in carotid atherosclerotic lesions. Nucleic acids were extracted from 18 carotid atherosclerotic lesions that had been collected surgically. Polymerase chain reaction was used to screen for specific genomic DNA from Chlamydia pneumoniae, cytomegalovirus and herpes simplex virus types 1 and 2. An original approach, based on the amplification by PCR of conserved bacterial 16S rDNA nucleotide sequences was also used to detect any bacterial species. The amplification product was identified by sequencing. Chlamydia pneumoniae, cytomegalovirus and herpes simplex 2 DNA were not detected in any of the samples. Herpes simplex 1 DNA was detected in 3 of the 18 samples. Genes encoding bacterial 16S rRNA were amplified and sequenced in eight atherosclerotic lesions. DNA sequences were identified by comparison with sequences registered in the GenBank database. These eight carotid atherosclerotic lesions were shown to contain several bacterial species belonging to human flora or the environment. The exact role of these microorganisms in the genesis or development of the atherosclerotic lesions remains unclear, but they may increase the inflammatory process or be an epiphenomenon.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12627283     DOI: 10.1007/s10096-002-0867-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  45 in total

1.  Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis.

Authors:  H S Markus; M Sitzer; D Carrington; M A Mendall; H Steinmetz
Journal:  Circulation       Date:  1999-08-24       Impact factor: 29.690

Review 2.  Chlamydia pneumoniae and atherosclerosis: what we know and what we don't know.

Authors:  M R Hammerschlag
Journal:  Pediatr Infect Dis J       Date:  2000-01       Impact factor: 2.129

3.  Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries.

Authors:  Marcello Valassina; Lucia Migliorini; Anna Sansoni; Guido Sani; Daniele Corsaro; Maria G Cusi; Pier E Valensin; Carla Cellesi
Journal:  J Med Microbiol       Date:  2001-03       Impact factor: 2.472

4.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

Review 5.  Emerging role of antibiotics in atherosclerosis.

Authors:  E P Gurfinkel; G Bozovich
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

6.  Rupture of a primary aortic aneurysm infected with Shewanella alga.

Authors:  M Paccalin; G Grollier; G le Moal; F Rayeh; C Camiade
Journal:  Scand J Infect Dis       Date:  2001

7.  Human infection with Halomonas venusta following fish bite.

Authors:  A von Graevenitz; J Bowman; C Del Notaro; M Ritzler
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

8.  Prior cytomegalovirus, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneous transluminal coronary angioplasty.

Authors:  J Carlsson; S Miketic; J Brom; R Ross; H Bachmann; U Tebbe
Journal:  Int J Cardiol       Date:  2000-04-28       Impact factor: 4.164

9.  Plasmid-borne genes code for an angular dioxygenase involved in dibenzofuran degradation by Terrabacter sp. strain YK3.

Authors:  Toshiya Iida; Yuki Mukouzaka; Kaoru Nakamura; Toshiaki Kudo
Journal:  Appl Environ Microbiol       Date:  2002-08       Impact factor: 4.792

10.  Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients.

Authors:  D L Paterson; J Hall; S J Rasmussen; P Timms
Journal:  Pathology       Date:  1998-05       Impact factor: 5.306

View more
  6 in total

1.  Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation.

Authors:  Afsar Rahbar; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

2.  Evaluation of the relationship between plaque formation leading to symptomatic carotid artery stenosis and cytomegalovirus by investigating the virus DNA.

Authors:  Metin Onur Beyaz; Murat Ugurlucan; Didem Melis Oztas; Mert Meric; Cenk Conkbayir; Ali Agacfidan; Mustafa Onel; Ufuk Alpagut
Journal:  Arch Med Sci Atheroscler Dis       Date:  2019-03-04

3.  Evaluation of chronic inflammation in the aetiology of venous insufficiency by investigating cytomegalovirus DNA.

Authors:  Metin O Beyaz; Emre Bozkurt; Mehmet A Onalan; Didem M Oztas; Mert Meric; Mustafa Ozer Ulukan; Ugur Coskun; Murat Ugurlucan
Journal:  Arch Med Sci       Date:  2019-05-17       Impact factor: 3.318

4.  Limited role for C. pneumoniae, CMV and HSV-1 in cerebral large and small vessel atherosclerosis.

Authors:  M Voorend; A J A M van der Ven; B Kubat; J Lodder; C A Bruggeman
Journal:  Open Neurol J       Date:  2008-07-25

5.  In silico analyses of metagenomes from human atherosclerotic plaque samples.

Authors:  Suparna Mitra; Daniela I Drautz-Moses; Morten Alhede; Myat T Maw; Yang Liu; Rikky W Purbojati; Zhei H Yap; Kavita K Kushwaha; Alexandra G Gheorghe; Thomas Bjarnsholt; Gorm M Hansen; Henrik H Sillesen; Hans P Hougen; Peter R Hansen; Liang Yang; Tim Tolker-Nielsen; Stephan C Schuster; Michael Givskov
Journal:  Microbiome       Date:  2015-09-03       Impact factor: 14.650

6.  Association of Chlamydia pneumoniae Infection With Atherosclerotic Plaque Formation.

Authors:  Omid Assar; Azim Nejatizadeh; Farzaneh Dehghan; Mohammad Kargar; Nader Zolghadri
Journal:  Glob J Health Sci       Date:  2015-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.